Prosecution Insights
Last updated: October 04, 2026

Saul Ewing LLP (Philadelphia)

Technology area: Biotechnology & Pharmaceuticals

159 pending office actions • 76 clients • 151 examiners • 80 art units • 0 of 159 (0%) have an AI response strategy ready

Analysis

Saul Ewing LLP (Philadelphia) manages 5437 career applications, with a focus on Biotechnology & Pharmaceuticals. The firm has a resolved allowance rate of 81.42 percent. Prosecution in these complex fields is intensive, averaging 3.94 office actions per allowance, which reflects the detailed examination process for life sciences. This average indicates a persistent approach to overcoming the technical and legal hurdles common in biotech.

The firm is currently handling 138 pending office actions. This active workload is part of its 5437 career applications. The 81.42 percent allowance rate indicates a strong ability to secure patents in the biotechnology and pharmaceutical sectors. While 3.94 office actions per allowance suggests a longer and more involved prosecution path, it is typical for the high-stakes and complex nature of the firm's primary technology area. Clients can expect a thorough and dedicated prosecution cycle based on these established metrics.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=5437 apps, methodology: how we score firms)

81.4%
Allowance Rate
n=5437
+0.67σ
Allowance Rate (norm)
n=5437
3.9
OAs to Allowance
n=2484
+0.02σ
OAs to Allow (norm)
n=2484
1114 days
Time to Allowance
n=2484
+17.2pp
Interview Lift
n=5437
31.9%
RCE Rate
n=5437
1.4%
Appeal Rate
n=5437

Rejection Performance (% of received rejections ultimately overcome)

71.8%
§101 Overcome
n=468
73.6%
§102 Overcome
n=1229
75.2%
§103 Overcome
n=2008
77.4%
§112 Overcome
n=1843

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
28%
Top-3 CPC Share
n=5437
0
Practitioners
n=5437
—
Apps / Practitioner
n=5437 (min 20)

Portfolio Summary

159
Total Pending OAs
104
Non-Final OAs
51
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 48 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

27
Overdue
1
Due this week
8
Due this month
8
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 48 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (27)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (8)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

81
Hard (51%)
58
Medium (36%)
19
Easy (12%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only4 (3%)
§101 + other19 (12%)
§103 only35 (22%)
§102 only5 (3%)
§112 only16 (10%)
Double-patenting only3 (2%)
Double-patenting + other18 (11%)
Multi-statute (no §101)58 (36%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

90
Life Sciences
57% of docket
6
Information Tech
4% of docket
4
Communications
3% of docket
1
Semiconductors
1% of docket
30
Mechanical / Eng
19% of docket
28
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,590 h
Manual time on pending OAs
318 h
Time saved (low, 20%)
556 h
Time saved (mid, 35%)
13.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YEN, ERIC L 2 85.1% +11.6%
WAGGONER, TIMOTHY R 2 71.6% +7.7%
LEE, CHIHYI NMN 2 33.7% +60.8%
SONG, JIANFENG 2 56.3% +33.2%
GREENE, CAROLYN LEE 2 65.3% +47.3%
AMICK, THOMAS RUSSE 2 73.1% +30.4%
SWARTZ, STEPHEN S 2 31.6% +25.9%
CHEN, STACY BROWN 2 66.1% +40.6%
RAZA, ZEHRA 1 45.3% +48.3%
HASAN, SYED HAROON 1 81.6% +15.5%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L —
19397080 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L —

Hard Cases (81)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18809238 MULTIDAY TIMED ENTRY TICKET SYSTEM FOR RECURRING EVENTS KIM, PATRICK 252d overdue
18327393 METHOD AND SERVER FOR PROVIDING FARE AVAILABILITIES, SUCH AS AIRFARE AVAILABILITIES SWARTZ, STEPHEN S 93d overdue
17378274 HUMAN MIRNAS FOR USE IN DIAGNOSIS, PROGNOSIS, AND THERAPY OF HUMAN CONDITIONS AND DISEASES DACE DENITO, ALEXANDRA GERALDINE 84d overdue
17222216 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS WHICH RELATE TO TRAVEL ARRANGEMENTS WALSH, EMMETT K 79d overdue
18631383 ADJUSTABLE INFANT TUB DEERY, ERIN LEAH 38d overdue
17759045 IMMUNOLOGICALLY OPTIMIZED BOTULINUM TOXIN LIGHT CHAIN VARIANTS DEVI, SARVAMANGALA 36d overdue
17340497 METHOD AND SERVER FOR PROVIDING A SET OF PRICE ESTIMATES, SUCH AS AIR FARE PRICE ESTIMATES SWARTZ, STEPHEN S 36d overdue
18276582 CCR4-Targeting Chimeric Antigen Receptor Cell Therapy EDGINGTONGIORDANO, FRANCESCA 23d overdue

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18327393 METHOD AND SERVER FOR PROVIDING FARE AVAILABILITIES, SUCH AS AIRFARE AVAILABILITIES SWARTZ, STEPHEN S 93d overdue
17340497 METHOD AND SERVER FOR PROVIDING A SET OF PRICE ESTIMATES, SUCH AS AIR FARE PRICE ESTIMATES SWARTZ, STEPHEN S 36d overdue
18483225 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 18d overdue
18004517 ENHANCING IMMUNE RESPONSES THROUGH TARGETED ANTIGEN EXPRESSION CHEN, STACY BROWN 8d
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 34d
18354345 COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID SONG, JIANFENG 39d
18034720 GENE SHUFFLED LYSSAVIRUS VACCINE CHEN, STACY BROWN 61d
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L —

Client Portfolio (76 clients)

Client (Assignee)Pending OAs
University of Pennsylvania 21
Yale University 20
THOMAS JEFFERSON UNIVERSITY 10
Drexel University 6
Rutgers University 4
U.S. Government 4
University of Colorado 4
U.S. Department of Veterans Affairs 4
UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED 3
Locus Robotics Corp. 3
10x Genomics 3
Rowan University 3
SKYSCANNER LIMITED 3
PRIVITAR LIMITED 2
Blackbird 2
AYR 2
The Carlstar Group LLC 2
WAKE FOREST UNIVERSITY HEALTH SCIENCES 2
Northwestern University 2
Wistar Institute 2
Arrival 2
Pylons, Inc. 1
Skyscanner Technology Limited 1
John Crane 1
Nexera Robotics Corp. 1
Mwc Family LP 1
X-System Limited 1
RESTORATIVE CARE OF AMERICA, INC. 1
Integrated Graphene Holding Limited 1
BAUSCH HEALTH IRELAND LIMITED 1
Global Sourcing Network LLC 1
Shenzhen Forward Pharmaceuticals Co., Limited 1
GrandPad, Inc. 1
RUNSIGNUP, INC. 1
The Code Registry, Inc. 1
American Superconductor 1
Stephane Krumenacker 1
The Trustees of the University of Pennsylvania 1
Zonhon Biopharma Institute, Inc. 1
George Mason Research Foundation, Inc. 1
Tomy 1
Dartmouth College 1
Harvard University 1
Texas Heart Institute 1
Inserm (institut National de La Sante Et de La Recherche Medicale) 1
Compass Pathfinder 1
Memsstar Limited 1
Teewinot Life Sciences Corporation 1
REWIRE HOLDING LTD. 1
Dermegen Inc. 1
UNCHARTED INDUSTRIES LIMITED 1
George Mason University 1
NATIONIAL CANCER CENTER 1
Baylor College of Medicine 1
Food and Drug Administration 1
ROBOCARS INC. 1
Pfizer 1
Sdg, Inc. 1
WAYNE STATE UNIVERSITY 1
Moeco 1
MEDAICA INC. 1
Stuzo, LLC 1
PhageNova Bio, Inc. 1
TUTCO, LLC 1
Matty Investments, LLC 1
BARUCH S. BLUMBERG INSTITUTE 1
Stanford University 1
VANDERBILT UNIVERSITY 1
Children's Medical Center 1
Arkeytyp 1
Novartis 1
Wisconsin Alumni Research Foundation 1
UNT 1
Perpetual Altruism Limited 1
EQUILUME LTD. 1
SEEREAL TECHNOLOGIES S.A. 1

Top Art Units

Art UnitApps
16266
16336
16224
36153
36553
16583
16283
37913
16133
16323

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA — Pending Nov 21, 2025
19397080 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA — Pending Nov 21, 2025
19287313 SYSTEMS AND METHODS FOR A PERMISSIONLESS DECENTRALIZED VIRTUAL ASSET NETWORK Pylons, Inc. RAZA, ZEHRA §101§103 Non-Final OA — Pending Jul 31, 2025
19259040 BROWSING METHODS, COMPUTER PROGRAM PRODUCTS, SERVERS AND SYSTEMS Skyscanner Technology Limited HASAN, SYED HAROON §101§102§103§112Other Non-Final OA — Pending Jul 03, 2025
19252753 SEALING RINGS John Crane Inc. PATEL, VISHAL A 3675 §102§103§112 Non-Final OA — Pending Jun 27, 2025
19243684 SYSTEM AND METHOD FOR CONTROLLING A SMART GRIPPING APPARATUS Nexera Robotics Corp. JOHNSON, KYLE T 3656 §102§103§112 Non-Final OA — Pending Jun 19, 2025
19198089 DIGITAL WATERMARKING WITHOUT SIGNIFICANT INFORMATION LOSS IN ANONYMIZED DATASETS Privitar Limited AMBAYE, SAMUEL 2431 §103 Non-Final OA — Pending May 04, 2025
19098726 SYSTEM AND METHOD FOR MONITORING A DWELLING Mwc Family LP PENDLETON, DIONNE §102§103 Non-Final OA — Pending Apr 02, 2025
19060987 METHOD AND SYSTEM FOR ANALYSING SOUND X-System Limited ZHU, QIN §103Other Non-Final OA — Pending Feb 24, 2025
19047424 LIFTING DEVICE HAVING A RETRACTABLE FOOT PEDAL TO LIFT PATIENTS TO STANDING POSITION Restorative Care Of America, Inc. HALL, LUKE F 3673 §102§112 Final Rejection 5d Pending Feb 06, 2025
18997039 VIDEO ENCODING AND DECODING BLACKBIRD PLC CHANG, DANIEL 2487 §103 Non-Final OA 45d overdue Pending Jan 18, 2025
19031738 ELECTRONIC VAPING SYSTEM Ayr Ltd. WILL, KATHERINE A 1747 §103 Non-Final OA — Pending Jan 18, 2025
19029666 E-CIGARETTE PERSONAL VAPORIZER Ayr Ltd. YAARY, ERIC 1755 §102§103§112 Non-Final OA — Pending Jan 17, 2025
18878564 NOVEL SARGASSUM-BASED POLYMER COMPOSITE FILAMENTS FOR 3D PRINTING AND METHOD OF MAKING THE SAME Rutgers, The State University Of New Jersey WILLIAMS, CEDRICK S 1749 §112 Final Rejection — Pending Dec 23, 2024
18990832 NON-PNEUMATIC TIRE AND METHOD OF MANUFACTURE THEREOF The Carlstar Group LLC BELLINGER, JASON R 3615 §103§112DP Non-Final OA — Pending Dec 20, 2024
18987814 METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH Yale University SUO, JOSHUA JUNGWOOK §103 Non-Final OA — Pending Dec 19, 2024
18982106 COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) Thomas Jefferson University SWITZER, JULIET CAROLINE 1682 §101§102§103§112DP Non-Final OA — Pending Dec 16, 2024
18972706 AN AUTONOMOUS MOBILE ROBOT WITH A TOTE MAGAZINE AND A TOTE ELEVATOR Locus Robotics Corp. WAGGONER, TIMOTHY R 3655 §102§103 Final Rejection — Pending Dec 06, 2024
18972744 TOTE MANIPULATOR MECHANISM Locus Robotics Corp. WAGGONER, TIMOTHY R 3655 §102Other Non-Final OA — Pending Dec 06, 2024
18972728 PRE-QUEUEING OF ORDER TOTES Locus Robotics Corp. HOLMES, JUSTIN 3655 §103Other Non-Final OA — Pending Dec 06, 2024
18967105 LASER-INDUCED CARBON NANOSTRUCTURES Integrated Graphene Holding Limited AMEEN, MOHAMMAD M 1742 DP Final Rejection — Pending Dec 03, 2024
18935127 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME BAUSCH HEALTH IRELAND LIMITED PATEL, RONAK C 1658 §102DPOther Non-Final OA — Pending Nov 01, 2024
18856855 BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR TARGETED DELIVERY The Trustees of the University of Pennsylvania DAVIS, BRIAN J §102§112 Non-Final OA — Pending Oct 14, 2024
18853928 SYSTEMS AND METHODS FOR CONDUCTING REMOTE NEURO-OPHTHALMIC EXAMINATIONS ON A MOBILE DEVICE Thomas Jefferson University BALAJI, KAVYA SHOBANA §102§103§112 Non-Final OA — Pending Oct 03, 2024
18904642 SYSTEMS AND METHODS FOR INTERCONNECTING MANUFACTURING NODES AND CONSUMER END POINTS Global Sourcing Network LLC JEANTY, ROMAIN 3624 §101§102 Non-Final OA 62d Pending Oct 02, 2024
18900131 METHODS FOR GENERATION OF SYNTHETIC SV2A PET FROM MRI IMAGES Yale University GEBRESLASSIE, WINTA §103 Non-Final OA — Pending Sep 27, 2024
18838136 QUINAZOLINE DERIVATIVE AS KRAS G12C MUTATION INHIBITOR Shenzhen Forward Pharmaceuticals Co., Limited REILLY, SOPHIA JANE §102§103§112 Non-Final OA — Pending Sep 24, 2024
18892956 DYNAMIC WALL FOR AUGMENTED REALITY Thomas Jefferson University SANZ, GABRIEL A §103 Non-Final OA — Pending Sep 23, 2024
18844474 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING, AMELIORATING, AND/OR PRVENTING COCAINE USE DISORDER Drexel University SAMSELL, RILLA MARIE §102§103§112 Non-Final OA — Pending Sep 06, 2024
18840040 METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH Yale University WHITE, DAWANNA SHAR-DAY §102§103§112 Non-Final OA — Pending Aug 20, 2024
18808807 METHOD OF RECONFIGURING A USER INTERFACE, AND SYSTEMS AND DEVICES IMPLEMENTING THE SAME Grandpad, Inc. TRAN, TAM T §103§112 Non-Final OA — Pending Aug 19, 2024
18809238 MULTIDAY TIMED ENTRY TICKET SYSTEM FOR RECURRING EVENTS Runsignup, Inc. KIM, PATRICK 3628 §101§103§112 Final Rejection 252d overdue Pending Aug 19, 2024
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS Wake Forest University Health Sciences COFFA, SERGIO 1658 §103DP Non-Final OA — Pending Aug 05, 2024
18835094 PROBE FOR MONITORING RNA SPLICING AND METHODS THEREOF Yale University KOVACH, KARA NICOLE §102§103§112 Non-Final OA — Pending Aug 01, 2024
18770145 SYSTEMS AND METHODS FOR STORAGE AND EVALUATION OF SOURCE CODE The Code Registry, Inc. BERMAN, STEPHEN DAVID §101§103 Non-Final OA — Pending Jul 11, 2024
18756390 MOBILE POWER SYSTEM American Superconductor Corporation JONES, JAMES WILLIAM 3615 §103§112 Final Rejection — Pending Jun 27, 2024
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases The United States Department of Veterans Affairs LEE, CHIHYI NMN 1628 §103§112 Non-Final OA 34d Pending Jun 21, 2024
18723103 SYSTEMS, DEVICES, AND METHODS FOR IMPLEMENTING COMPUTERIZED AMSLER GRID FOR EVALUATION OF VISUAL DISTURBANCES Stephane Krumenacker BROOME, SHARRIEF I 3792 §102§112 Non-Final OA — Pending Jun 21, 2024
18750780 ANTI-CAR COMPOSITIONS AND METHODS The Trustees of the University of Pennsylvania BOESEN, AGNIESZKA §102§103 Non-Final OA — Pending Jun 21, 2024
18750876 RHEOLOGICALLY MODIFIED LIQUID METAL DEVICES AND RELATED SYSTEMS AND METHODS The Regents of the University of Colorado SMOOT, MORIAH SIMONE MCMIL 3791 §102§103§112 Non-Final OA — Pending Jun 21, 2024
18720823 COMPUTER-IMPLEMENTED METHODS AND ASSOCIATED SYSTEMS FOR DETECTING MALIGNANCY The Trustees of the University of Pennsylvania JACOB, OOMMEN 3797 §112 Non-Final OA 33d Pending Jun 17, 2024
18716088 ANISAMIDE-CONTAINING LIPIDS AND COMPOSITIONS AND METHODS OF USE THEREOF The Trustees of the University of Pennsylvania SONG, JIANFENG 1613 §112 Final Rejection — Pending Jun 03, 2024
18670290 COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES The Trustees of the University of Pennsylvania LEONARD, ARTHUR S §102§103§112DP Non-Final OA — Pending May 21, 2024
18710640 UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF Zonhon Biopharma Institute, Inc. SPANGLER, JOSEPH RANKIN 1656 §101§102§103§112 Non-Final OA — Pending May 16, 2024
18654097 INJECTABLE HYDROGEL COMPOSITIONS AND METHODS OF USE THEREOF Drexel University LAZARO, DOMINIC 1611 §112 Non-Final OA — Pending May 03, 2024
18706936 SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR THERAPEUTIC EUS ANCHOR Thomas Jefferson University FRITH, SEAN A 3798 §103 Non-Final OA 49d overdue Pending May 02, 2024
18705568 METHOD FOR TRACKING DISTRIBUTION OF A SHARED DIGITAL MEDIA FILE BLACKBIRD PLC SAINT CYR, JEAN D 2425 §103 Final Rejection 100d overdue Pending Apr 28, 2024
18705295 Compositions and Methods for Diagnosis and Therapy of Viral Infection George Mason Research Foundation, Inc. GILL, RACHEL B §101§102§112 Non-Final OA — Pending Apr 26, 2024
18644807 DNA mapping and sequencing on linearized DNA molecules Drexel University GREENE, CAROLYN LEE 1758 §103§112 Non-Final OA — Pending Apr 24, 2024
18640092 COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTOANTIBODY RECEPTOR T CELLS The Trustees of the University of Pennsylvania OUSPENSKI, ILIA I §101§102§112DP Non-Final OA — Pending Apr 19, 2024
18635885 USE OF ICOS-BASED CARS TO ENHANCE ANTITUMOR ACTIVITY AND CAR PERSISTENCE The Trustees of the University of Pennsylvania BERTOGLIO, VALARIE E 1632 Other Final Rejection — Pending Apr 15, 2024
18701027 IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE Yale University VAJDA, KRISTIN ANN 1622 §102§103§112DP Non-Final OA — Pending Apr 12, 2024
18631383 ADJUSTABLE INFANT TUB Tomy International, Inc. DEERY, ERIN LEAH 3754 §102§103 Non-Final OA 38d overdue Pending Apr 10, 2024
18699103 FLAVONOID DERIVATIVES WITH GABAA RECEPTOR ACTIVITY AND METHODS OF USE Rutgers, The State University Of New Jersey SHIM, DAVID M. 1626 §102§112 Non-Final OA — Pending Apr 05, 2024
18624860 TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY The Trustees of the University of Pennsylvania AMICK, THOMAS RUSSE DP Non-Final OA — Pending Apr 02, 2024
18621312 ANTI-NMDAR2B ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS OF USE The Trustees of Dartmouth College JUEDES, AMY E §112 Non-Final OA — Pending Mar 29, 2024
18695487 COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS The Trustees of the University of Pennsylvania AZPURU, CARLOS A 1611 §102§112Other Non-Final OA — Pending Mar 26, 2024
18694284 COMPOUNDS AND METHODS FOR TREATING CANCERS THAT ARE MGMT DEFICIENT REGARDLESS OF MMR STATUS Yale University NEAGU, IRINA 1629 §103§112 Non-Final OA — Pending Mar 21, 2024
18611505 Substituted Bimane Compounds and Methods of Use Thereof The Trustees of the University of Pennsylvania GONZALEZ, LUISALBERTO 1624 §103 Non-Final OA — Pending Mar 20, 2024
18693056 PROCESS FOR EMBEDDING A DIGITAL WATERMARK IN TOKENISED DATA Privitar Limited KING, JOHN B 2498 §112 Final Rejection — Pending Mar 18, 2024
18692064 COMPOSITION FOR TREATING, PREVENTING, OR AMELIORATING MELANOMA AND METHOD THEREOF Thomas Jefferson University DEKARSKE, MADELINE MCGUIRE 1622 §103 Non-Final OA — Pending Mar 14, 2024
18690785 METHODS, SYSTEMS AND COMPOSITIONS FOR RESTORATION AND PRESERVATION OF INTACT ORGANS IN A MAMMAL Yale University YOH, JULIUS FRANCIS 1633 §102§112DP Non-Final OA — Pending Mar 11, 2024
18686115 IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS The Regents of the University of Colorado EZELUOMBA, MIRIAM NCHEKWUBECHU 1776 §103§112 Non-Final OA — Pending Feb 23, 2024
18684563 TREATMENT COMPOSITIONS AND METHODS The United States Department of Veterans Affairs HEASLEY, MEGHAN CHRISTINE 1626 §102§103§112 Non-Final OA — Pending Feb 16, 2024
18444024 COMPOSITIONS, SYSTEMS AND METHODS FOR ENZYME OPTIMIZATION 10X Genomics, Inc. GREENE, CAROLYN LEE §112 Non-Final OA — Pending Feb 16, 2024
18684124 COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY Yale University GRASER, JENNIFER E 1645 §101§102§103§112DP Non-Final OA — Pending Feb 15, 2024
18430757 THIOAMIDE-MODIFIED PEPTIDES AND USES THEREOF President and Fellows of Harvard College CHANDRA, GYAN §103 Non-Final OA — Pending Feb 02, 2024
18293711 DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR The Trustees of the University of Pennsylvania CORDAS, EMILY ANN 1632 §103§112 Non-Final OA — Pending Jan 30, 2024
18292464 ISOFORM SPECIFIC AGONISTS TARGETING AKT KINASE Texas Heart Institute BARSKY, JARED 1628 §102§103§112 Non-Final OA — Pending Jan 26, 2024
18292247 COMPOSITIONS AND METHODS FOR ENHANCING CAR T CELL EFFICACY THROUGH THE ENGINEERED SECRETION OF C. PERFRINGENS NEURAMINIDASE The Trustees of the University of Pennsylvania METCALF, MATTHEW CURRAN §102§103§112 Non-Final OA — Pending Jan 25, 2024
18417617 COMPOSITIONS AND METHODS FOR SPATIAL AND TEMPORAL CONTROL OF NEUROTROPHIC GROWTH FACTOR EXPRESSION The United States Department of Veterans Affairs AMICK, THOMAS RUSSE 1638 §102§103 Non-Final OA — Pending Jan 19, 2024
18416340 TUMOR BED IMPLANT FOR MULTIMODALITY TREATMENT OF AT RISK TISSUE SURROUNDING A RESECTION CAVITY Drexel University DORNA, CARRIE R §112DP Non-Final OA — Pending Jan 18, 2024
18573728 COMPOSITIONS AND METHODS FOR PERMEABILIZING THE BLOOD BRAIN BARRIER INSERM HOPKINS, SAMANTHA LAKE §103§112 Non-Final OA — Pending Dec 22, 2023
18573604 Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same The United States Department of Veterans Affairs JONES, DAMERON LEVEST §103§112 Non-Final OA — Pending Dec 22, 2023
18572447 INDOCARBOCYANINE LIPID DERIVATIVES FOR IN VIVO CARGO DELIVERY Northwestern University MCANANY, JOHN D 1625 §102§103§112 Final Rejection — Pending Dec 20, 2023
18566373 Tissue-Engineered Rostral Migratory Stream for Neuronal Replacement The United States Department of Veterans Affairs PYLA, EVELYN Y 1633 §102§103§112 Non-Final OA — Pending Dec 01, 2023
18565565 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME Compass Pathfinder Ltd. JACKSON, SHAWQUIA 1626 §112 Non-Final OA — Pending Nov 30, 2023
18562321 METHOD OF MANUFACTURING A MICROSTRUCTURE Memsstar Limited DUCLAIR, STEPHANIE P. 1713 §103 Non-Final OA — Pending Nov 19, 2023
18387669 SYSTEMS AND METHODS FOR METABOLOME ANALYSIS 10X Genomics, Inc. FLINDERS, JEREMY C §102DP Non-Final OA — Pending Nov 07, 2023
18289875 GENE THERAPY FOR DENT DISEASE Wake Forest University Health Sciences GU, QINHUA 1633 §103 Final Rejection 60d Pending Nov 07, 2023
18557449 SYNTHESIS OF CBN AND CBNV Teewinot Life Sciences Corporation COUGHLIN, MATTHEW P 1626 §103§112 Non-Final OA 61d Pending Oct 26, 2023
18557099 SYSTEMS AND METHODS FOR FIBER ZONE-DRAWING AND/OR ZONE-ANNEALING Rowan University LIU, XUE H 1742 §103§112 Non-Final OA — Pending Oct 25, 2023
18555214 METHODS TO DETERMINE TREATMENT EFFICACY WITH GAMMA-DELTA T CELLS The Trustees of the University of Pennsylvania LANDSMAN, ROBERT S 1647 §103 Non-Final OA — Pending Oct 12, 2023
18483225 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases The United States Department of Veterans Affairs LEE, CHIHYI NMN 1628 §103§112Other Final Rejection 18d overdue Pending Oct 09, 2023
18285889 NON-PNEUMATIC TIRE WITH MULTI ANGLE TENSION CONTROL REINFORCEMENTS The Carlstar Group LLC KOTTER, KIP T 3615 §102§103 Final Rejection — Pending Oct 06, 2023
18554134 SYSTEMS AND METHODS FOR FRAUD PREVENTION Rewire Holding Ltd. VIG, NARESH 3622 §101§103 Final Rejection 17d overdue Pending Oct 05, 2023
18477584 Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific Antibody The Trustees of the University of Pennsylvania SANG, HONG 1646 §112DP Non-Final OA — Pending Sep 29, 2023
18473802 IMIDE-BASED MODULATORS OF PROTEOLYSIS AND METHODS OF USE Yale University MCKOY, QUINCY ANDRE 1626 §102 Non-Final OA — Pending Sep 25, 2023
18552086 CAR-T DELIVERY OF SYNTHETIC PEPTIDE THERAPEUTICS The Trustees of the University of Pennsylvania PETERS, ALEC JON 1641 §102§103§112Other Non-Final OA — Pending Sep 22, 2023
18043436 N-Linked Glycosylation Inhibitors and Methods of Using Same Yale University WEDDINGTON, KEVIN E 1629 §102Other Non-Final OA 34d Pending Sep 22, 2023
18368780 PRESERVATIVE COMPOSITIONS Dermegen Inc. COHEN, MICHAEL P 1612 §103 Final Rejection 34d Pending Sep 15, 2023
18549716 IMPROVED BLOCKCHAIN RELYING ON ADVANCED CONSENSUS UNCHARTED INDUSTRIES LIMITED PHAN, TUANKHANH D 2154 §103 Final Rejection 96d overdue Pending Sep 08, 2023
18549252 COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING T CELL DYSFUNCTION The Trustees of the University of Pennsylvania PERSONS, JENNA L 1637 §101§102§103§112 Non-Final OA — Pending Sep 06, 2023
18461041 Heteromultivalent Nucleic Acid Scaffolds and Uses Thereof George Mason University GARYU, LIANKO G 1654 §103§112 Non-Final OA — Pending Sep 05, 2023
18276582 CCR4-Targeting Chimeric Antigen Receptor Cell Therapy Nationial Cancer Center EDGINGTONGIORDANO, FRANCESCA 1643 §102§103§112 Non-Final OA 23d overdue Pending Aug 09, 2023
18274514 Compounds and Methods for Preventing, Treating, or Ameliorating Airway Disease The Wistar Institute WARD, PAUL V 1622 §112 Non-Final OA — Pending Jul 27, 2023
18357810 MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME Yale University ROSENTHAL, ANDREW S 1613 §103 Final Rejection 3d overdue Pending Jul 24, 2023
18262037 BET SUBFAMILY INHIBITORS AND METHODS USING SAME BAYLOR COLLEGE OF MEDICINE RAO, PADMAJA S 1627 §102§112 Non-Final OA — Pending Jul 19, 2023
18354345 COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID Food And Drug Administration SONG, JIANFENG 1613 §103DP Final Rejection 39d Pending Jul 18, 2023
18258483 SYSTEMS AND METHODS FOR LATENCY-TOLERANT ASSISTANCE OF AUTONOMOUS VEHICLES Robocars Inc. REFAI, RAMSEY 3664 §102 Non-Final OA — Pending Jun 20, 2023
18327393 METHOD AND SERVER FOR PROVIDING FARE AVAILABILITIES, SUCH AS AIRFARE AVAILABILITIES Skyscanner Limited SWARTZ, STEPHEN S 3625 §101Other Final Rejection 93d overdue Pending Jun 01, 2023
18322395 PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT Pfizer, Inc. HAMA, JOANNE 1647 §103§112Other Non-Final OA 17d overdue Pending May 23, 2023
18321429 LIPID-BASED NANOPARTICLES AND USE OF SAME IN OPTIMIZED INSULIN DOSING REGIMENS Sdg, Inc. RONEY, CELESTE A 1612 §112DP Non-Final OA — Pending May 22, 2023
18034720 GENE SHUFFLED LYSSAVIRUS VACCINE Thomas Jefferson University CHEN, STACY BROWN 1672 §102§112 Final Rejection 61d Pending May 01, 2023
18034245 Lipid Prophylactic Brain Injury Treatment The United States Department of Veterans Affairs CHONG, YONG SOO 1623 §102§103 Non-Final OA — Pending Apr 27, 2023
18135836 Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule Wayne State University ARON, KIMBERLY A 1633 §102§103§112 Final Rejection — Pending Apr 18, 2023
18248192 SYSTEM INCLUDING A SERVER SYSTEM, A PLURALITY OF GATEWAYS AND A PLURALITY OF OBJECTS Moeco Iot Inc. BILODEAU, DAVID 2648 §103 Final Rejection 134d overdue Pending Apr 06, 2023
18029422 MEDICAL PORT PROTECTION ADAPTERS Thomas Jefferson University RADOMSKI, MARTIN ADAM 3783 §102§103§112 Final Rejection — Pending Mar 30, 2023
18115945 Compositions and Methods for Treating, Ameliorating and/or Preventing Cancer and Kits for the Same The Wistar Institute SCOTLAND, REBECCA LYNN 1615 §102§103§112 Final Rejection — Pending Mar 01, 2023
18024142 TELEMEDICINE SYSTEM Medaica Inc. TU, AURELIE H 3791 §103 Final Rejection — Pending Mar 01, 2023
18042993 Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting Yale University KIM, SEONG JONG 1621 §112 Final Rejection 4d overdue Pending Feb 24, 2023
18174434 WALLET STEERING: SYSTEM, ENGINE, METHOD, AND PROFESSIONAL SERVICES TO PROGRAMMATICALLY, PRECISELY, AND PROFITABLY STEER CONSUMER PURCHASES FROM ONE BUSINESS TO ANOTHER AND/OR ONE PRODUCT/SERVICE TO ANOTHER, AND/OR ONE PAYMENT TENDER TO ANOTHER Stuzo, LLC PUJOLS-CRUZ, MARJORIE 3624 §101§103 Final Rejection 29d Pending Feb 24, 2023
18161712 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins Yale University LEE, JIA-HAI 1658 §103DPOther Non-Final OA — Pending Jan 30, 2023
18156442 COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS The Trustees of the University of Pennsylvania LOCKARD, JON MCCLELLAND 1647 §112Other Non-Final OA — Pending Jan 19, 2023
18096668 ELECTRON-ENHANCED ATOMIC LAYER DEPOSITION (EE-ALD) METHODS AND DEVICES PREPARED BY SAME The Regents of the University of Colorado MCCLURE, CHRISTINA D 1718 §103 Non-Final OA 56d Pending Jan 13, 2023
18004517 ENHANCING IMMUNE RESPONSES THROUGH TARGETED ANTIGEN EXPRESSION Phagenova Bio, Inc. CHEN, STACY BROWN 1672 §103 Non-Final OA 8d Pending Jan 06, 2023
18014206 A BATTERY MODULE AND A VEHICLE Arrival Ltd. ESTES, JONATHAN WILLIAM 1725 §102§103§112 Non-Final OA — Pending Jan 03, 2023
18091615 OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME Rowan University HELM, CARALYNNE E 1615 §103§112 Final Rejection — Pending Dec 30, 2022
18088596 COMPUTER IMPLEMENTED METHOD FOR THE AUTOMATED ANALYSIS OR USE OF DATA UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED ARMSTRONG, ANGELA A 2659 §101Other Final Rejection — Pending Dec 25, 2022
18002710 PanK Modulators and Methods Using Same Yale University VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §102§103§112Other Non-Final OA 40d Pending Dec 21, 2022
18002477 Methods of Treating, Ameliorating, Shortening Duration, and/or Reversing Symptoms and/or Complications of a Coronavirus Infection Yale University RZECZYCKI, PHILLIP MATTHEW 1625 §103 Final Rejection 29d Pending Dec 19, 2022
18011106 METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS The Regents of the University of Colorado ROSWELL, JESSICA MARIE 1767 §103 Non-Final OA — Pending Dec 16, 2022
18000957 COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS Yale University MOLOYE, TITILAYO 1632 §103DP Final Rejection — Pending Dec 07, 2022
17928170 Compositions and Methods for Detecting Respiratory Viruses Including Coronaviruses The Trustees of the University of Pennsylvania BAUSCH, SARAE L 1699 §101§102§112 Non-Final OA 3d overdue Pending Nov 28, 2022
17999324 AN INTEGRATED DIELECTROPHORESIS-TRAPPING AND NANOWELL TRANSFER APPROACH TO ENABLE DOUBLE-SUB-POISSON SINGLE-CELL RNA-SEQUENCING Yale University CHUNDURU, SURYAPRABHA 1681 §103 Non-Final OA 9d overdue Pending Nov 18, 2022
18056505 GAS HEATER Tutco, LLC KHLOK, BONITA 3761 §103§112 Non-Final OA — Pending Nov 17, 2022
17985490 DYNAMIC GENERATION OF A STOCK PORTFOLIO GENERATED BY SOCIAL MEDIA CONTENT Matty Investments, LLC BUI, TOAN D. 3693 §101§103 Final Rejection — Pending Nov 11, 2022
17920663 Compounds and Compositions for Treating Hematologic Malignancies BARUCH S. BLUMBERG INSTITUTE BURKETT, DANIEL JOHN 1600 §112 Non-Final OA — Pending Oct 21, 2022
17938428 COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAS) Thomas Jefferson University BOESEN, CHRISTIAN C 1684 §101§112 Non-Final OA — Pending Oct 06, 2022
17936654 METHOD OF TREATING OR AMELIORATING CANCERS DRIVEN BY RECEPTOR TYROSINE KINASE FUSION ONCOGENES, AND COMPOSITIONS FOR THE SAME The Trustees of the University of Pennsylvania ROBINSON, MIKHAIL O'DONNEL 1627 §103 Non-Final OA 10d overdue Pending Sep 29, 2022
17995072 METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISEASES AND DISORDERS Yale University MI, QIUWEN 1655 §102§103§112 Non-Final OA — Pending Sep 29, 2022
17933052 Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune Cells The Board Of Trustees Of The Leland Stanford Junior University PATTERSON, SARAH COOPER 1675 DP Final Rejection — Pending Sep 16, 2022
17932466 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME VANDERBILT UNIVERSITY ROMERO, KRISTEN WANG 1626 §112DP Non-Final OA — Pending Sep 15, 2022
17898995 MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME Rutgers, The State University Of New Jersey ROGERS, JAMES WILLIAM 1618 §103 Final Rejection 26d Pending Aug 30, 2022
17759045 IMMUNOLOGICALLY OPTIMIZED BOTULINUM TOXIN LIGHT CHAIN VARIANTS Children'S Medical Center Corporation DEVI, SARVAMANGALA 1645 §102§112 Final Rejection 36d overdue Pending Jul 19, 2022
17791684 COMPLEXES OF N-HETEROCYCLIC CARBENES FOR TRANSITION METAL CATALYSIS Rutgers, The State University Of New Jersey CHEN, PO-CHIH 1621 §112 Final Rejection 27d Pending Jul 08, 2022
17782914 COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER Yale University BOECKELMAN, JACOB A 1655 §102DP Final Rejection — Pending Jun 06, 2022
17768145 ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS Yale University HIBSHMAN, SARAH GRACE 1693 §103§112DP Final Rejection 70d overdue Pending Apr 11, 2022
17693011 Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same The United States Department of Veterans Affairs PERREIRA, MELISSA JEAN 1618 §102§103DP Non-Final OA — Pending Mar 11, 2022
17687376 SYSTEMS AND METHODS FOR BARCODING CELLS AND CELL BEADS 10X Genomics, Inc. CASH, KAILEY ELIZABETH 1683 §102§103Other Non-Final OA — Pending Mar 04, 2022
17637004 METHODS FOR ENHANCING DNA DAMAGE AND APOPTOSIS OF LEUKEMIC CELLS Thomas Jefferson University SIMMONS, CHRIS E 1622 §112 Non-Final OA — Pending Feb 21, 2022
17582186 PORTABLE, COMPUTER-PERIPHERAL APPARATUS INCLUDING A UNIVERSAL SERIAL BUS (USB) CONNECTOR Arkeytyp Ip Limited DANG, PHONG H 2184 §103 Non-Final OA — Pending Jan 24, 2022
17628106 Modulators of Excitatory Amino Acid Transporters and Methods Using Same Drexel University KUCHARCZK, JED A 1623 §102 Non-Final OA 92d overdue Pending Jan 18, 2022
17507951 BACTERICIDAL COATING COMPOSITIONS AND METHODS USING SAME Rowan University GREENE, IVAN A 1619 §103 Final Rejection 72d overdue Pending Oct 22, 2021
17602277 METHODS AND COMPOSITIONS FOR PROGRAMMING T CELL DIFFERENTIATION AND ENHANCING T CELL PROLIFERATION The Trustees of the University of Pennsylvania WESTON, ALYSSA G 1633 §102§103 Final Rejection — Pending Oct 07, 2021
17593475 METHODS, COMPUTER-READABLE MEDIA, AND SYSTEMS FOR ASSESSING WOUNDS AND CANDIDATE TREATMENTS Drexel University LUO, JAMMY NMN 1686 §101§103 Non-Final OA — Pending Sep 20, 2021
17432868 COMBINATION THERAPIES OF EGFRVIII CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS Novartis AG CHASE, CAROL ANN 1646 §102§103§112 Final Rejection — Pending Aug 20, 2021
17445285 ENHANCING SUBCUTANEOUS INJECTION AND TARGET TISSUE ACCUMULATION OF NANOPARTICLES VIA CO-ADMINISTRATION WITH MACROPINOCYTOSIS INHIBITORY NANOPARTICLES (MINP) Northwestern University WESTERBERG, NISSA M 1618 §103 Final Rejection 28d overdue Pending Aug 17, 2021
17427180 DEVICES AND METHODS FOR MEASURING BRAIN STATE Wisconsin Alumni Research Foundation COOPER, JONATHAN EPHRAIM 3791 §103 Final Rejection 29d Pending Jul 30, 2021
17378274 HUMAN MIRNAS FOR USE IN DIAGNOSIS, PROGNOSIS, AND THERAPY OF HUMAN CONDITIONS AND DISEASES Thomas Jefferson University DACE DENITO, ALEXANDRA GERALDINE 1636 §101§103§112 Final Rejection 84d overdue Pending Jul 16, 2021
17348988 ROBOTIC PRODUCTION ENVIRONMENT FOR VEHICLES Arrival Ltd. CULLEN, TANNER L 3656 §103 Non-Final OA 121d overdue Pending Jun 16, 2021
17340497 METHOD AND SERVER FOR PROVIDING A SET OF PRICE ESTIMATES, SUCH AS AIR FARE PRICE ESTIMATES Skyscanner Limited SWARTZ, STEPHEN S 3625 §101 Non-Final OA 36d overdue Pending Jun 07, 2021
17222216 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS WHICH RELATE TO TRAVEL ARRANGEMENTS Skyscanner Limited WALSH, EMMETT K 3628 §101 Final Rejection 79d overdue Pending Apr 05, 2021
17193907 PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS University Of North Texas Health Science Center AT Fort Worth HANEY, AMANDA MARIE 1682 §112DPOther Final Rejection 69d Pending Mar 05, 2021
15734382 COMPUTER IMPLEMENTED METHOD AND SYSTEM FOR UPDATING A DATABASE SYSTEM FOR A BLOCKCHAIN VERSION CONTROL SYSTEM; COMPUTER IMPLEMENTED METHODS OF AUCTIONING AN ITEM FOR A SELLER, AND COMPUTER IMPLEMENTED METHOD OF UPDATING A SMART CONTRACT Perpetual Altruism Limited KHATRI, NILESH B 3699 §101§103 Non-Final OA — Pending Dec 02, 2020
16971995 METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC The Trustees of the University of Pennsylvania CONNORS, ALEXANDRA F 1634 §103§112 Final Rejection — Pending Aug 21, 2020
16487970 BOVINE HEADPIECE AND METHOD Equilume Ltd. MULLINS, JESSICA LYNN 3792 §103 Final Rejection 15d Pending Aug 22, 2019
16485550 LIGHT GUIDE DEVICE AND DISPLAY DEVICE FOR REPRESENTING SCENES Seereal Technologies S.A. WILKES, ZACHARY W 2872 §103§112 Final Rejection 13d Pending Aug 13, 2019
15327794 SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS The Trustees of the University of Pennsylvania POPA, ILEANA 1633 §103 Final Rejection 5d overdue Pending Jan 20, 2017

Managing Saul Ewing LLP (Philadelphia)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month